Kronos Bio
About Kronos Bio
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases.
At Kronos Bio, we have two molecules that have emerged from our product engine. KB-0742, our CDK9 inhibitor, is being evaluated in a phase 1/2 clinical trial as a treatment for patients with MYC-dependent tumors such as triple negative breast cancer, non-small cell lung cancer and ovarian cancer, as well as patients with transcription factor fusion-driven cancers and other transcriptionally addicted cancers including chordomas, sarcomas and small cell lung cancer. Our new development candidate, KB-9558, targets the KAT domain of p300, a critical node of the IRF4 TRN, which is a core oncogenic transcription program that drives multiple myeloma.
Additionally, Kronos Bio began a discovery collaboration with Genentech in January 2023. Our companies are working together to advance novel therapies against transcriptional targets in oncology.
For additional information about our community guidelines, visit: https://bit.ly/3FfcDQW.
Company Details
5M-10M
Biotechnology Research
51-200 employees
Public Company
San Mateo, California
United States
Frequently Asked Questions about
What is Kronos Bio's industry?
Kronos Bio operates in the Biotechnology Research industry and is headquartered in United States.
How many employees does Kronos Bio have?
Kronos Bio has approximately 51-200 employees employees.
Where is Kronos Bio's based?
Kronos Bio is based in San Mateo, California, United States.
Is Kronos Bio publicly listed?
Yes. Kronos Bio is a publicly traded company.
How can I contact Kronos Bio's investor relations team?
You can reach Kronos Bio’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.